Fourteenth André Schroeder Research Prize Awarded To Frank Schwarz

Main Category: Dentistry
Article Date: 03 May 2007 - 12:00 PDT

email to a friend   printer friendly   opinions  

The winner of the coveted André Schroeder Research Prize, an annual award worth CHF 20 000 for the advancement of dental research and development, was announced in New York today by Straumann's President and CEO, Gilbert Achermann. Speaking at the ITI[1] World Symposium, a leading scientific meeting in implant and restorative dentistry and oral tissue regeneration, Mr Achermann announced that this year's award has been won by Dr Frank Schwarz of the Department of Oral Surgery, Westdeutsche Kieferklinik, at the University of Düsseldorf in Germany[2].

Frank Schwarz commended for work on hydrophilic implant surfaces

Dr Schwarz (34), who is the fourteenth recipient of this prestigious prize, was selected by the independent jury for his scientific investigation of the effects of surface hydrophilicity and microtopography of titanium dental implants on soft and hard tissue integration.

The winning research investigated early tissue reactions to Straumann's third generation implant surface technology, SLActive, in comparison with conventional roughened and machined surface implants. It concluded that both soft and hard tissue integration was mainly influenced by surface hydrophilicity, rather than by microtopography. The research demonstrated that the attachment of soft gum tissue as well as bone attachment were enhanced by the new hydrophilic surface. One important implication of these findings is that the improved soft tissue attachment around the implant forms a natural barrier to oral bacteria and thus may prevent infection. These and other observations are being investigated further in a clinical setting and could translate into enhanced implant treatment outcomes and a higher standard of patient care.

About the André Schroeder Research Prize

First presented in 1992, the Prize serves to promote new scientific findings in oral implantology and related fields. It is given in honor of the late Professor Schroeder, who pioneered dental implantology and whose life's work contributed greatly to modern dentistry. Sponsored by Straumann, the André Schroeder Research Prize furthers illustrates the company's commitment in the field of research and development, where it ranks among the leading contributors in the industry.

Previous winners are: Dieter Weingart (1992), Franz Sutter (1993), Daniel Buser (1995), David Cochran (1996), Joachim Hermann (1997), Siegfried Heckmann (1998), Alexandra Behneke (2000), Leif Persson (2001), Lisa Mayfield (2002), Yuelian Liu (2003), Michael Hänggi (2004), Xiaolong Zhu (2005), and Karthikeyan Subramani (2006).

[1] International Team for Implantology
[2] Chairman: Prof. Dr J. Becker

Concerning forward-looking statements

This media release contains certain "forward-looking statements", which can be identified by the use of terminology such as "may", "could", or similar wording. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group ("Group") to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group's products, the potential for the Group's products to become obsolete, the Group's ability to defend its intellectual property, the Group's ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group's ability to generate revenues and profitability, the Group's ability to realize expansion projects or projects to establish subsidiaries in a timely manner, and the Group's ability to recruit and retain key employees. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this release. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise.

About Straumann

Headquartered in Basel, Switzerland, the Straumann Group (SWX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann employs approximately 1650 people worldwide and its products and services are available in more than 60 countries through its broad network of distribution subsidiaries and partners.

http://www.straumann.com

• Additional
• References
• Citations